search
Back to results

An Implantable Microstimulator for the Chronic Treatment of Urinary Urgency-Frequency Syndrome

Primary Purpose

Overactive Bladder

Status
Completed
Phase
Phase 3
Locations
United States
Study Type
Interventional
Intervention
bion
Sponsored by
Boston Scientific Corporation
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Overactive Bladder focused on measuring Urgency-Frequency, Syndrome, Urinary, Refractory, Stimulation, Nerve, Neuromodulation, Microstimulator, bion, Pudendal, Overactive bladder

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Key Inclusion criteria: Age 18 years and above. Diagnosed with urinary urgency-frequency syndrome. Have no reported history of urethral obstruction/stricture, bladder calculi or bladder tumor. Have normal upper urinary tract function. Be capable of giving informed consent. Be capable and willing to follow all study related procedures. Key Exclusion Criteria: Have any active implantable device regardless of whether stimulation status is ON or OFF. Are pregnant as confirmed by a urine pregnancy test or plan to become pregnant during the following 12 month period. Less than one year post partum and/or are breast-feeding. Have any large passive implant that contains metal located within 30 cm of the chair pad while seated (e.g., hip replacement). Have conditions requiring magnetic resonance imaging (MRI) evaluation. Have conditions requiring diathermy procedures. Have an inability to operate the bion Remote Control and bion Recharging System either by self or caregiver. Have diabetes with peripheral nerve involvement or have severe uncontrolled diabetes. Have history of coagulopathy or bleeding disorder. Have pelvic pain in the absence of voiding dysfunction. Have anatomical restrictions such that the study device placement is not possible. Are currently participating or have participated within the past 30 days in any clinical investigation involving or impacting urinary or renal function. Cannot independently comprehend and complete the questionnaires.

Sites / Locations

  • Arizona Health Sciences Center
  • The Department of Urology, Stanford University Medical Center
  • Milestone Medical Research
  • Walter Reed Army Medical Center
  • Overland Park Regional Medical Center
  • William Beaumont Hospital
  • Cornerstone Medical Specialty Center
  • New York University
  • Cleveland Clinic Foundation
  • The Pelvic and Sexual Health Institute
  • Dallas Center for Pelvic Medicine

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Sham Comparator

Arm Label

1

2

Arm Description

Stimulation On from Initial Activation up to the 12 month post-activation. Stimulation Off from 12 months post-activation until 45 days after the 12 month visit. Stimulation On from 45 days post 12 month visit and on.

No stimulation until 45 days post-implant. Stimulation On from 45 days post-implant and on.

Outcomes

Primary Outcome Measures

Average Number of Voids Per Day
Freedom From Major Complications

Secondary Outcome Measures

Full Information

First Posted
August 17, 2005
Last Updated
October 25, 2013
Sponsor
Boston Scientific Corporation
search

1. Study Identification

Unique Protocol Identification Number
NCT00131573
Brief Title
An Implantable Microstimulator for the Chronic Treatment of Urinary Urgency-Frequency Syndrome
Official Title
Battery Powered Bion Clinical Investigation: Bion - An Implantable Microstimulator for the Chronic Treatment of Refractory Urinary Urgency-Frequency Syndrome
Study Type
Interventional

2. Study Status

Record Verification Date
October 2013
Overall Recruitment Status
Completed
Study Start Date
May 2004 (undefined)
Primary Completion Date
March 2008 (Actual)
Study Completion Date
December 2012 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Boston Scientific Corporation

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The goal of this study is to investigate the safety and effectiveness of a new implanted device designed to treat Urinary Urgency-Frequency Syndrome.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Overactive Bladder
Keywords
Urgency-Frequency, Syndrome, Urinary, Refractory, Stimulation, Nerve, Neuromodulation, Microstimulator, bion, Pudendal, Overactive bladder

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
118 (Actual)

8. Arms, Groups, and Interventions

Arm Title
1
Arm Type
Experimental
Arm Description
Stimulation On from Initial Activation up to the 12 month post-activation. Stimulation Off from 12 months post-activation until 45 days after the 12 month visit. Stimulation On from 45 days post 12 month visit and on.
Arm Title
2
Arm Type
Sham Comparator
Arm Description
No stimulation until 45 days post-implant. Stimulation On from 45 days post-implant and on.
Intervention Type
Device
Intervention Name(s)
bion
Intervention Description
battery powered bion microstimulator
Primary Outcome Measure Information:
Title
Average Number of Voids Per Day
Time Frame
12 months
Title
Freedom From Major Complications
Time Frame
5 years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Key Inclusion criteria: Age 18 years and above. Diagnosed with urinary urgency-frequency syndrome. Have no reported history of urethral obstruction/stricture, bladder calculi or bladder tumor. Have normal upper urinary tract function. Be capable of giving informed consent. Be capable and willing to follow all study related procedures. Key Exclusion Criteria: Have any active implantable device regardless of whether stimulation status is ON or OFF. Are pregnant as confirmed by a urine pregnancy test or plan to become pregnant during the following 12 month period. Less than one year post partum and/or are breast-feeding. Have any large passive implant that contains metal located within 30 cm of the chair pad while seated (e.g., hip replacement). Have conditions requiring magnetic resonance imaging (MRI) evaluation. Have conditions requiring diathermy procedures. Have an inability to operate the bion Remote Control and bion Recharging System either by self or caregiver. Have diabetes with peripheral nerve involvement or have severe uncontrolled diabetes. Have history of coagulopathy or bleeding disorder. Have pelvic pain in the absence of voiding dysfunction. Have anatomical restrictions such that the study device placement is not possible. Are currently participating or have participated within the past 30 days in any clinical investigation involving or impacting urinary or renal function. Cannot independently comprehend and complete the questionnaires.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Tamara Baynham, PhD
Organizational Affiliation
Boston Scientific, Neuromodulation
Official's Role
Study Director
Facility Information:
Facility Name
Arizona Health Sciences Center
City
Tucson
State/Province
Arizona
ZIP/Postal Code
85724-5077
Country
United States
Facility Name
The Department of Urology, Stanford University Medical Center
City
Stanford
State/Province
California
ZIP/Postal Code
94305-5118
Country
United States
Facility Name
Milestone Medical Research
City
Englewood
State/Province
Colorado
ZIP/Postal Code
80112
Country
United States
Facility Name
Walter Reed Army Medical Center
City
Washington
State/Province
District of Columbia
ZIP/Postal Code
20307-5001
Country
United States
Facility Name
Overland Park Regional Medical Center
City
Overland Park
State/Province
Kansas
ZIP/Postal Code
66214
Country
United States
Facility Name
William Beaumont Hospital
City
Royal Oak
State/Province
Michigan
ZIP/Postal Code
48073
Country
United States
Facility Name
Cornerstone Medical Specialty Center
City
Woodbury
State/Province
Minnesota
ZIP/Postal Code
55125
Country
United States
Facility Name
New York University
City
New York
State/Province
New York
ZIP/Postal Code
10016
Country
United States
Facility Name
Cleveland Clinic Foundation
City
Cleveland
State/Province
Ohio
ZIP/Postal Code
44195
Country
United States
Facility Name
The Pelvic and Sexual Health Institute
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19146
Country
United States
Facility Name
Dallas Center for Pelvic Medicine
City
Dallas
State/Province
Texas
ZIP/Postal Code
75231
Country
United States

12. IPD Sharing Statement

Learn more about this trial

An Implantable Microstimulator for the Chronic Treatment of Urinary Urgency-Frequency Syndrome

We'll reach out to this number within 24 hrs